|

HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT

RECRUITINGN/ASponsored by Azienda USL Reggio Emilia - IRCCS
Actively Recruiting
PhaseN/A
SponsorAzienda USL Reggio Emilia - IRCCS
Started2026-06
Est. completion2028-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07579065

Summary

This is a feasibility study to implement a Survivorship Care (SC) Plan for patients with hematologic cancer undergoing hematopoietic stem cell transplantation (HSCT). The study evaluates if the intervention is feasible within the Italian national health system, focusing on retention rates, quality of life, unmet needs and caregiver burden

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients with hematologic cancer candidates for HSCT (autologous or allogeneic) and their informal caregivers
* Able to provide informed consent
* Able to communicate in Italian

Exclusion Criteria:

* Patients or caregivers with comorbidities hindering participation (e.g., significant cognitive limitations)

Conditions5

CancerCancer SurvivorshipHematologic NeoplasmHematopoietic Stem Cell TransplantationSurvivorship

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.